Sign in with Google. Opens in new tab
bearish
Kitazato IPO - Isn’t Particularly Enticing Apart from the Dividend Yield
366 Views11 Jun 2025 00:00
Kitazato (368A JP) manufactures and sells medical devices and products for fertility treatment. It aims to raise around US$130m in its Japan IPO.
What is covered in the Full Insight:
- Introduction to Kitazato IPO
- Company Overview
- Earnings and Revenue Projections
- Valuation Analysis
- Summary and Investment Perspective
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 2-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »Top Unpaywalled Insights
More »- "The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
- The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Kitazato IPO Trading - Demand Was Strong24 Jun 2025
- Kitazato (368A JP): Greenshoe Nudges It Closer to Global Index Inclusion, but Shortfall Remains15 Jun 2025
- Kitazato Pre-IPO - Past Sales Have Been Steady but Slowing03 Jun 2025
- Primo Global Pre-IPO: Driven by Domestic Demand as International Ops Falter02 Jun 2025
x